“…The pathological hallmark of the disease is the presence of nuclear inclusions of aggregation-prone expanded ATXN3 in the patients' brains. Although ATXN3 is ubiquitously expressed (Paulson et al, 1997), only restricted neuronal populations of the central nervous system (CNS) are classically described as affected, namely the cerebellar dentate nucleus, pallidum, substantia nigra, thalamus, subthalamic, red, and pontine nuclei, cranial nerve nuclei and the anterior horn and Clarke's column of the spinal cord (Romanul et al, 1977;Rosenberg et al, 1976;Woods and Schaumburg, 1972). Recent pathological studies have suggested that the extension of CNS degeneration in MJD patients at end stages may be more widespread, including the visual, auditory, vestibular, somatosensory, ingestion-related, dopaminergic and cholinergic systems (Rub et al, 2008).…”